Survival Rates Similar Between TAVR Tx and Replacement Sx for Aortic Stenosis Patients

This article originally appeared here.
Similar rate of any-cause death, disabling stroke for intermediate-risk patients with severe aortic stenosis
Similar rate of any-cause death, disabling stroke for intermediate-risk patients with severe aortic stenosis

HealthDay News — For intermediate-risk patients with severe aortic stenosis, outcomes are similar for transcatheter aortic-valve replacement (TAVR) and surgical aortic valve replacement, according to a study published online April 2 in the New England Journal of Medicine. The research is being published to coincide with the annual meeting of the American College of Cardiology, held from April 2 to 4 in Chicago.

Martin B. Leon, MD, from the Columbia University Medical Center in New York City, and colleagues randomized 2,032 intermediate-risk patients with severe aortic stenosis to undergo TAVR or surgical replacement. The patients were enrolled into two cohorts before randomization: 76.3% in the transfemoral-access cohort and 23.7% in the transthoracic-access cohort.

The researchers found that the rate of death from any cause or disabling stroke was similar between the groups (P=0.001 for noninferiority). The Kaplan-Meier event rates were 19.3 and 21.1 percent in the TAVR and surgery groups, respectively, at two years (hazard ratio, 0.89; 95% confidence interval, 0.73 to 1.09). TAVR correlated with a lower rate of death or disabling stroke than surgery in the transfemoral-access cohort (hazard ratio, 0.79; 95 percent confidence interval, 0.62 to 1.00); however, outcomes were similar for TAVR and surgery in the transthoracic-access cohort.

"In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke," the authors write.

The study was funded by Edwards Lifesciences.

Abstract
Full Text
Editorial
More Information

Loading links....